AMG 757 and AMG 404 in Subjects With Small Cell Lung Cancer (SCLC)
NCT04885998
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Small Cell Lung Cancer
Interventions
DRUG:
Tarlatamab
DRUG:
AMG 404
Sponsor
Amgen